BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33887730)

  • 1. Prophylactic Treatment in Hereditary Angioedema Is Associated with Reduced Anxiety in Patients in Leipzig, Germany.
    Zarnowski J; Rabe M; Kage P; Simon JC; Treudler R
    Int Arch Allergy Immunol; 2021; 182(9):819-826. PubMed ID: 33887730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
    Mendivil J; Murphy R; de la Cruz M; Janssen E; Boysen HB; Jain G; Aygören-Pürsün E; Hirji I; Devercelli G
    Orphanet J Rare Dis; 2021 Feb; 16(1):94. PubMed ID: 33602292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
    Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
    Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States.
    Banerji A; Davis KH; Brown TM; Hollis K; Hunter SM; Long J; Jain G; Devercelli G
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):600-607. PubMed ID: 32169514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
    Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema.
    Nunes FL; Ferriani MPL; Moreno AS; Langer SS; Maia LSM; Ferraro MF; Sarti W; Bessa Junior J; Cunha D; Suffritti C; Dias MM; Januário YC; daSilva LLP; Aragon DC; Caballero T; Arruda LK
    Int Arch Allergy Immunol; 2021; 182(8):697-708. PubMed ID: 33657571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.
    Nordenfelt P; Nilsson M; Lindfors A; Wahlgren CF; Björkander J
    Allergy Asthma Proc; 2017 Nov; 38(6):447-455. PubMed ID: 28855002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and anxiety in patients with hereditary angioedema.
    Fouche AS; Saunders EF; Craig T
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):371-5. PubMed ID: 24428960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.
    Vanya M; Watt M; Shahraz S; Kosmas CE; Rhoten S; Costa-Cabral S; Mendivil J; Devercelli G; Weller K
    J Patient Rep Outcomes; 2023 Apr; 7(1):33. PubMed ID: 37012445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary angioedema: Epidemiology and burden of disease.
    Lumry WR; Settipane RA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S08-S13. PubMed ID: 33109318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of disease on daily activities, emotions and quality of life of patients with hereditary angioedema].
    Nicolas A; Launay D; Duprez C; Citerne I; Morell-Dubois S; Sobanski V; Hachulla É; Staumont-Sallé D; Farhat MM; Sanges S
    Rev Med Interne; 2021 Sep; 42(9):608-615. PubMed ID: 34158189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
    Castaldo AJ; Jervelund C; Corcoran D; Boysen HB; Christiansen SC; Zuraw BL
    Allergy Asthma Proc; 2021 Mar; 42(2):108-117. PubMed ID: 33581742
    [No Abstract]   [Full Text] [Related]  

  • 13. An international survey assessing the effects of the duration of attack-free period on health-related quality of life for patients with hereditary angioedema.
    Itzler R; Lumry WR; Sears J; Braverman J; Li Y; Brennan CJ; Koch GG
    Orphanet J Rare Dis; 2024 Jun; 19(1):241. PubMed ID: 38909246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of COVID-19 on hereditary angioedema activity and quality of life.
    Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF
    Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.
    Otani IM; Christiansen SC; Busse P; Camargo CA; Zuraw BL; Riedl MA; Banerji A
    J Allergy Clin Immunol Pract; 2017; 5(1):128-134.e4. PubMed ID: 27665386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Disease Burden and Societal Costs of Hereditary Angioedema.
    Fijen LM; Klein PCG; Cohn DM; Kanters TA
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2468-2475.e2. PubMed ID: 36990433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current state of hereditary angioedema management: a patient survey.
    Banerji A; Busse P; Christiansen SC; Li H; Lumry W; Davis-Lorton M; Bernstein JA; Frank M; Castaldo A; Long JF; Zuraw BL; Riedl M
    Allergy Asthma Proc; 2015; 36(3):213-7. PubMed ID: 25976438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States.
    Tachdjian R; Johnson KE; Casso D; Oliveria SA; Devercelli G; Jain G
    Allergy Asthma Proc; 2020 May; 41(3):172-182. PubMed ID: 32375961
    [No Abstract]   [Full Text] [Related]  

  • 19. The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology.
    Bygum A; Aygören-Pürsün E; Caballero T; Beusterien K; Gholizadeh S; Musingarimi P; Wait S; Boysen H
    BMC Dermatol; 2012 Apr; 12():4. PubMed ID: 22536794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study.
    Hews-Girard J; Goodyear MD
    Allergy Asthma Clin Immunol; 2021 Jun; 17(1):61. PubMed ID: 34187550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.